Data integrity lapses at Strides’s Puducherry plant; USFDA may widen scrutiny

The warning letter addressed to Arun Kumar, CEO and MD of the company, was issued on July 1 said its investigator found a blue binder containing CGMP records, including batch records for US drug products, discarded with other records in a 55-gallon drum in the scrap yard

from Moneycontrol Business News https://www.moneycontrol.com/news/business/data-integrity-lapses-at-strides’s-puducherry-plant-usfda-may-widen-scrutiny_12761061.html